SALVATORE, ELENA
 Distribuzione geografica
Continente #
NA - Nord America 1.479
EU - Europa 779
AS - Asia 260
AF - Africa 8
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 2
OC - Oceania 1
Totale 2.533
Nazione #
US - Stati Uniti d'America 1.439
IT - Italia 303
CN - Cina 206
NL - Olanda 124
IE - Irlanda 80
FI - Finlandia 72
DE - Germania 46
SE - Svezia 40
UA - Ucraina 40
CA - Canada 36
VN - Vietnam 30
GB - Regno Unito 23
FR - Francia 16
IN - India 13
RO - Romania 11
ZA - Sudafrica 8
ES - Italia 7
IR - Iran 6
BE - Belgio 4
EU - Europa 4
RU - Federazione Russa 4
BG - Bulgaria 3
BZ - Belize 3
TR - Turchia 3
BR - Brasile 2
CH - Svizzera 2
AU - Australia 1
DK - Danimarca 1
GR - Grecia 1
LT - Lituania 1
MX - Messico 1
PH - Filippine 1
SI - Slovenia 1
TW - Taiwan 1
Totale 2.533
Città #
Chandler 347
Amsterdam 120
Millbury 98
Princeton 81
Napoli 66
Nanjing 64
Jacksonville 61
Boston 49
Naples 46
Des Moines 39
Beijing 38
Wilmington 34
Ottawa 33
Dong Ket 30
Lawrence 24
Nanchang 21
Shenyang 17
Woodbridge 17
Norwalk 16
San Jose 16
Hebei 14
Houston 14
Jiaxing 13
Tianjin 11
Ashburn 10
Falls Church 10
Redwood City 9
San Mateo 9
Ann Arbor 8
Milan 8
Muizenberg 8
Rome 8
Solopaca 8
Boardman 7
Changsha 7
Dublin 7
Augusta 6
Fairfield 6
Kunming 6
Mugnano Di Napoli 6
Paris 6
Indiana 5
Timisoara 5
Birmingham 4
Campagna 4
Chengdu 4
Mezzolombardo 4
New York 4
Nuremberg 4
Orange 4
Saint Petersburg 4
Sant'antimo 4
Ardabil 3
Atlanta 3
Barcelona 3
Belize City 3
Buffalo 3
Eugene 3
Grand Rapids 3
Hangzhou 3
Lanzhou 3
London 3
Minneapolis 3
New Delhi 3
Northampton 3
Sofia 3
Toronto 3
Arlington 2
Bangalore 2
Benidorm 2
Bordeaux 2
Caserta 2
Courcelles 2
Dearborn 2
Ficarazzi 2
Fremont 2
Hammond 2
Las Vegas 2
Mumbai 2
Pomeroy 2
Portici 2
Salem 2
Seattle 2
Shanghai 2
Sunnyvale 2
Telese 2
Vanves 2
Waanrode 2
Acerra 1
Afragola 1
Ankara 1
Ariano Irpino 1
Ascoli Piceno 1
Bacoli 1
Bari 1
Basel 1
Beaverton 1
Bengaluru 1
Bergamo 1
Brandizzo 1
Totale 1.543
Nome #
DNA damage signatures in peripheral blood cells as biomarkers in prodromal huntington disease 67
Brain structural damage in Friedreich's ataxia. 63
Reduced Cancer Incidence in Huntington's Disease: Analysis in the Registry Study 60
PINK1 homozygous W437X mutation in a patient with apparent dominant transmission of parkinsonism. 54
Assessing usability of a robotic-based AAL system: A pilot study with dementia patients 53
Assessment of retinal vascular network in amnestic mild cognitive impairment by optical coherence tomography angiography 49
Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study 45
Characterization of nigrostriatal dysfunction in spinocerebellar ataxia 17 44
Reduced striatal [123I]FP-CIT binding in SCA2 patients without parkinsonism 42
Altered functional connectivity of interoception in illness anxiety disorder 42
Relative frequencies of CAG expansions in spinocerebellar ataxia and dentatorubropallidoluysian atrophy in 116 Italian families 41
Cerebellar blood flow in spinocerebellar degenerations: a single photon emission tomography study in 28 patients. 40
Genotyping of Toxoplasma gondii strain directly from human CSF samples of congenital toxoplasmosis clinical case 40
Closing-in Phenomenon in Huntington's Disease: A Neuropsychological Marker of Frontal/Executive Dysfunction 40
Perseverative Behavior on Verbal Fluency Task in Patients with Huntington's Disease: a Retrospective Study on a Large Patient Sample 40
Why do some Friedreich's ataxia patients retain tendon reflexes? A clinical, neurophysiological and molecular study. 39
Atorvastatin combined to interferon to verify the efficacy (ACTIVE) in relapsing-remitting active multiple sclerosis patients: a longitudinal controlled trial of combination therapy. 39
Relationship between simultaneously acquired resting-state regional cerebral glucose metabolism and functional MRI: A PET/MR hybrid scanner study. 39
Simultaneous resting-state FDG-PET/fMRI in Alzheimer Disease: Relationship between glucose metabolism and intrinsic activity 39
Autonomic disorders and myocardial 123I-metaiodobenzylguanidine scintigraphy in Huntington's disease 38
Autonomic nervous system abnormalities in spinocerebellar ataxia type 2: a cardiovascular neurophysiologic study. 37
A multilayer perceptron neural network-based approach for the identification of responsiveness to interferon therapy in multiple sclerosis patients 37
Responsiveness of different rating instruments in spinocerebellar ataxia patients 36
Functional MRI signal fluctuations highlight altered resting brain activity in Huntington’s disease 36
A randomized clinical trial of lithium in multiple system atrophy. 35
Steroid treatment in Ataxia-Telangiectasia induces alterations of functional magnetic resonance imaging during prono-supination task. 33
Suicidal ideation in a European Huntington's disease population. 33
[18F]FDG uptake of the normal spinal cord in PET/MR imaging: comparison with PET/CT imaging 33
Cerebral blood flow in spinocerebellar degenerations: a single photon emission tomography study in 28 patients. 32
Arithmetic Word-Problem Solving as Cognitive Marker of Progression in Pre-Manifest and Manifest Huntington's Disease 32
Internal jugular vein blood flow in multiple sclerosis patients and matched controls. 31
Progression of striatal and extrastriatal degeneration in multiple system atrophy: a longitudinal diffusion-weighted MR study. 30
Brain white matter tracts degeneration in Friedreich ataxia. An in vivo MRI study using tract-based spatial statistics and voxel-based morphometry. 30
CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion. 30
The emotional impact of COVID-19 outbreak in amyotrophic lateral sclerosis patients: evaluation of depression, anxiety and interoceptive awareness 30
Clinical manifestations of intermediate allele carriers in Huntington disease 30
Benign hereditary chorea: clinical and neuroimaging features in an Italian family. 29
A novel NKX2.1 mutation in a family with hypothyroidism and benign hereditary chorea. 28
Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis. 28
Supratentorial and infratentorial damage in spinocerebellar ataxia 2: A diffusion-weighted MRI study. 28
Optical coherence tomography angiography findings in Huntington’s disease 28
Two novel CYP7B1 mutations in Italian families with SPG5: a clinical and genetic study. 27
Constructional Apraxia is related to Different Cognitive Defect's across Dementia 27
The “crab sign”: an imaging feature of spinocerebellar ataxia type 48 27
Serum transferrin receptor levels in Friedreich's and other degenerative ataxias. 26
Grey matter loss in relapsing-remitting multiple sclerosis: a voxel-based morphometry study. 26
Normal and mutant HTT interact to affect clinical severity and progression in Huntington disease. 26
Axial diffusivity is increased in the degenerating superior cerebellar peduncles of Friedreich's ataxia. 25
Default-Mode Network Changes in Huntington's Disease: An Integrated MRI Study of Functional Connectivity and Morphometry. 25
Insulin Sensitivity and Early-Phase Insulin Secretion in Normoglycemic Huntington's Disease Patients 25
The Italian Alzheimer's Disease Neuroimaging Initiative (I-ADNI): Validation of Structural MR Imaging. 25
Variable phenotype in a P102L Gerstmann-Sträussler-Scheinker Italian family. 24
Neuropsychological assessment, quantitative MRI and ApoE gene polymorphisms in a series of MS patients treated with IFN beta-1b. 23
Brain structural damage in spinocerebellar ataxia type 2. A voxel-based morphometry study. 23
Comparison between a dual-head and a brain-dedicated SPECT system in the measurement of the loss of dopamine transporters with [123I]FP-CIT. 22
Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkin disease. 22
Chronic cerebrospinal venous insufficiency in multiple sclerosis: a highly prevalent age-dependent phenomenon 22
The complex phenotype of spinocerebellar ataxia type 48 in eight unrelated Italian families 22
SPINOCEREBELLAR ATAXIA 2: A BRAIN DIFFUSION-WEIGHTED MRI STUDY 21
Brain white matter damage in SCA1 and SCA2. An in vivo study using voxel-based morphometry, histogram analysis of mean diffusivity and tract-based spatial statistics 21
Serum transferrin receptor levels in Friedreich's and other degenerative ataxias. 21
High Prevalence of Spinal Magnetic Resonance Imaging Findings in Asymptomatic Young Adults (18-22 Yrs) Candidate to Air Force Flight 21
Surface-enhanced Raman spectroscopy of tears: toward a diagnostic tool for neurodegenerative disease identification 21
Possible gluten sensitivity in multiple system atrophy 20
Benign hereditary chorea due to a novel mutation of the thyroid transcription factor-1 gene. 20
Neuroimaging follow-up in a case of Rasmussen's encephalitis with dyskinesias. 19
Depression comorbidity in spinocerebellar ataxia. 19
Diffusion-weighted imaging in multiple system atrophy: a comparison between clinical subtypes. 19
Growth hormone response to arginine test distinguishes multiple system atrophy from Parkinson's disease and idiopathic late-onset cerebellar ataxia 18
Predictors of survival in a Huntington's disease population from southern Italy. 18
Cortical sources of resting state EEG rhythms are related to brain hypometabolism in subjects with Alzheimer's disease: an EEG-PET study 18
INNOVATIVE APPROACHES TO SERVICE INTEGRATIONADDRESSING THE UNMET NEEDS OF IRRITABLE BOWEL SYNDROME PATIENTS AND NEW APPROACHES FOR THE NEEDS OF IBS PATIENTS 17
In vivo imaging of neurotransmission and brain receptors in dementia 17
Observing Huntington's disease: the European Huntington's Disease Network's REGISTRY. 17
A Randomized, Double-blind, Placebo-Controlled Study of Latrepirdine in Patients With Mild to Moderate Huntington Disease. 17
Progression of brain atrophy in spinocerebellar ataxia type 2: a longitudinal tensor-based morphometry study. 17
Spinocerebellar ataxia 48 presenting with ataxia associated with cognitive, psychiatric, and extrapyramidal features: A report of two Italian families 17
Spinocerebellar ataxia type 48: last but not least 17
Nigrostriatal involvement in ataxia with oculomotor apraxia type 1 16
Growth hormone response to arginine test differentiates between two subgroups of Huntington's disease patients 16
Stimulation of growth hormone release in multiple system atrophy, Parkinson's disease and idiopathic cerebellar ataxia. 16
Neurodegeneration in friedreich's ataxia is associated with a mixed activation pattern of the brain. A fMRI study. 16
NMDA receptor gene variations as modifiers in Huntington disease: a replication study. 16
Structural connectivity in a single case of progressive prosopagnosia: The role of the right inferior longitudinal fasciculus. 15
Whole body cholesterol metabolism is impaired in Huntington's disease. 14
Radial peripapillary vessel density as early biomarker in preperimetric glaucoma and amnestic mild cognitive impairment 14
Neuroimaging follow-up in a case of Rasmussen's encephalitis with dyskinesias. 13
Cortical sources of resting state electroencephalographic alpha rhythms deteriorate across time in subjects with amnesic mild cognitive impairment. 13
Correlation of disease severity and regional brain tissue loss in relapsing-remitting multiple sclerosis: a voxel-based morphometry study in a large population 13
Identification by [99mTc]ECD SPECT of anterior cingulate hypoperfusion in progressive supranuclear palsy, in comparison with Parkinson's disease 12
Resting state cortical electroencephalographic rhythms and white matter vascular lesions in subjects with Alzheimer's disease: an Italian multicenter study. 12
Multiple sclerosis and hepatitis C virus infection are associated with single nucleotide polymorphisms in interferon pathway genes 12
Reduced striatal [123 I]FP-CIT binding in SCA2 patients without parkinsonism 12
PRIN2015 n.2015KBL78T "Profilazione e adattivita' per una robotica assistiva incentrata sull'utente" 12
Molecular and imaging biomarkers in Alzheimer’s disease: A focus on recent insights 12
Incremental value of amyloid-PET versus CSF in the diagnosis of Alzheimer’s disease 12
Multiple Sclerosis: Cerebral Circulation Time 11
Observing Huntington's Disease: the European Huntington's Disease Network's REGISTRY. 11
Histogram analysis of DTI-derived indices reveals pontocerebellar degeneration and its progression in SCA2. 11
Digital Health Service for Identification of Frailty Risk Factors in Community-Dwelling Older Adults: The SUNFRAIL+ Study Protocol 11
Totale 2.662
Categoria #
all - tutte 8.403
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.403


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019165 0 0 41 5 8 52 27 4 11 7 6 4
2019/2020288 119 11 10 22 15 6 5 1 2 18 38 41
2020/2021344 16 26 25 30 24 34 18 16 56 16 52 31
2021/2022595 10 4 8 5 5 33 9 26 83 68 108 236
2022/2023897 112 61 39 52 121 83 6 79 138 131 58 17
2023/2024191 39 91 61 0 0 0 0 0 0 0 0 0
Totale 2.744